FDA warns against purchase, consumption of unregistered turmeric, ginger powder
by UNTV News and Rescue | Posted on Tuesday, 12 March 2019 04:44 PM
MANILA, Philippines – The Food and Drug Administration (FDA) warns the public against consumption of food products that were not registered and were not issued with proper authorization by the agency.
Specifically, the FDA advises consumers to be vigilant in purchasing ginger and turmeric powder or tea brands that are not checked by the agency in pursuant to R.A. 9711 or the Food and Drug Administration Act of 2009.
Some brands of ginger tea and turmeric powder that are banned by the FDA include:
Dollie’s Pure Turmeric Powder, Sugar Free
Dollie’s Pure Turmeric Tea (Bag)
IJ Turmeric Products Turmeric Instant Herbal Tea
Turmeric Fortified With 95% Curcumin C3 Complex Dietary Supplement
G Stuff Turmeric and Ginger Tea
G Stuff Amazing Tea
Reyes Turmeric Tea
Ginger root is known for its powerful medicinal benefits aside from being one of the favorite spices in the world.
Turmeric, a yellow-colored root also from the ginger family, is not only a popular spice in East India and Middle Eastern cuisines, it also boasts of anti-inflammatory agents as well as other properties that are helpful in curing several conditions such menstrual problems, hemorrhaging, toothaches, bruises, chest pain, flatulence, blood in the urine, among others.
Based on the FDA post-marketing surveillance (PMS) activities, these “unregistered food products have not gone through evaluation and testing process” and the agency “cannot guarantee their quality and safety.”
“Consumption of such violative products may pose potential health hazard to the consuming public,” the FDA said on its website.
The agency reminds consumers to be cautious in buying and consuming unregistered food products and urges the public to always check and verify product registration through the FDA website www.fda.gov.ph.
Meanwhile, concerned establishments are warned not to sell such violative food products until they get proper registration and authorization.
Regulatory actions and sanctions shall be strictly pursued against violators.
The agency also asked local government units (LGU) and law enforcement agencies “to ensure that these products are not sold or made available in their localities or areas of jurisdiction.”
The public is further advised to report continuous sale or distribution of unregistered food products to www.fda.gov.ph/ereport, or send an e-mail to email@example.com, or call the Center for Food Regulation and Research (CFRR) hotline (02) 857-1900 local 8115 and 8112. – Marje Pelayo
by admin | Posted on Thursday, 29 March 2018 02:52 AM
FILE PHOTO: President Rodrigo Duterte
MANILA, Philippines — The manufacture and selling of fake medicines spell economic sabotage and risk to the health of the public.
President Rodrigo Duterte has directed the Philippine National Police (PNP) to arrest those who are responsible for these wrongdoings.
“The president has ordered the chief PNP to arrest all persons who manufacture, import, distribute, sell, administer, dispense fake drugs. They will be charged with economic sabotage. Those acts undermine not only the economy. It also threatens the security of the nation,” said Presidential Chief Legal Counsel Salvador Panelo.
This order came after the Food and Drug Administration (FDA) released its warning to the public on the proliferation of fake paracetamol Biogesic 500 mg tablets in the market.
FDA also reminded everyone to buy medicines from establishments duly authorized by the FDA.
Those who import, sell and distribute fake drugs violate the Republic Act 9711 or Food and Drug Administration Act of 2009 as well as Republic Act 8203 or the special law on counterfeit drugs which have due penalties. — Rosalie Coz | UNTV News & Rescue
by UNTV News | Posted on Wednesday, 7 February 2018 02:07 PM
MANILA, Philippines – The Senate Blue Ribbon Committee once again questioned the process of procurement of the controversial Dengvaxia vaccines.
For Senate Blue Ribbon Committee chairman, Senator Richard Gordon, there seems to be a manipulation on the procurement of the said vaccines.
The Food and Drug Administration (FDA) and former Health Secretary Janette Garin refuted the allegations.
“I would say that it follows the process po,” FDA Deputy Dir. Gen. for Field regulatory Operations Office Ma. Lourdes Santiago said.
“Because if no CPR (Certificate of Product Registration) is forthcoming, then I will directly inform the president na imposible po ang dengue vaccine (that a dengue vaccine is impossible).” Garin said.
But for some health experts, the mass vaccination of more than 800,000 children is still questionable, as the conduct of such undertaking entails long and thorough preparation.
“I will not take any risk . . . especially on a massive scale,” UP-PGH Dr. Juliet Sio-Aguilar said.
“The patient has the right to know. Hindi nalaman ng tao ‘yan (The public did not know). Prescription based ka, bakit ka magma-mass vaccination (It’s prescription-based, why would you conduct a mass vaccination?),” said health reform advocate, Dr. Anthony Leachon.
On the other hand, health experts believe there is no need to worry for now regarding the effects of Dengavaxia.
“Sa daming kanilang na bakunahan ng Dengvaxia, talagang mayroon at mayroon doon na mga normal diseases that will happen with or without Dengvaxia,” Aguilar said.
( Translation: With the number of people vaccinated with Dengvaxia, there will inevitably be normal diseases that will happen with or without Dengvaxia.)
“Results from the clinical trials . . . in general safe ho,” infectious diseases specialist, Dr. Mary Ann Lansang said.
They said it is premature for them to come up with any conclusion until they have seen the result of the probe conducted by the Dengue Investigative Task Force.
Meanwhile, DOH Secretary Francisco Duque said, the Dengvaxia issue has greatly affected the other government’s Immunization Program.
“And to date, I think it’s down to 57% it’s substantial 30% reduction, that’s truly a cause of concern,” Duque said.
As the hearing rolled on, the Blue Ribbon Committee has issued subpoenas to Public Attorney Office (PAO) Chief Persida Acosta and PAO Forensic Laboratory Director Dr. Erwin Erfe who conducted a separate investigation on the issue.
Some senators are calling for unity on handling the issue to establish an airtight case against the persons involved in the controversy.
“Eh di ba dapat tayo ay magsama-sama, magtulong-tulong? Ang hindi ko maintindihan bakit ayaw nilang makipagtulungan, ano ba ang meron?” said Senate Committee on Health & Demography chairman, Sen. Joseph Victor Ejercito.
(Are we not supposed to work together? I don’t understand why they refuse to cooperate. What’s the reason?)
“Ang ayaw ko lang sa kanila, sinasabi nila Dengvaxia. Hihina ang kaso ng gobyerno kapag sinasabi niyo Dengvaxia tapos wala namang napapatunayan,” Gordon said.
(What I don’t like about them is they keep saying it’s Dengvaxia. The government’s case will weaken if you keep saying Dengvaxia without any proof.)
The Blue Ribbon Committee will set another hearing on the Dengvaxia controversy. – Nel Maribojoc | UNTV News & Rescue
by UNTV News | Posted on Thursday, 7 December 2017 02:58 PM
MANILA, Philippines – The World Health Organization (WHO) is aware of the concerns of Filipinos, especially mothers, whose children have received dengue vaccination.
In a statement released by world agency on its website, Tuesday, it clarified that it did not recommend to countries the introduction of the controversial Dengvaxia vaccine into their national immunization programs, stated in the position paper it released last July 2016.
Instead, the international body stated the matters that should be taken into consideration by national governments in deciding whether or not to use the said vaccine.
WHO also said that the previous leadership of the Philippine’s Department of Health (DOH) already launched the Dengue Mass Immunization Program even before it released its advisory regarding the vaccine.
Until now, WHO is still waiting for the results of the expert studies on the possible effects of Dengvaxia to individuals who received the vaccine.
The WHO also supports the decision of the DOH and the Food and Drug Administration (FDA) to order the pharmaceutical giant Sanofi Pastuer to halt the market sale and distribution of Dengvaxia.
According to DOH Asst. Sec Lyndon Lee Suy, who already held a meeting to form recommendations to countries regarding the proper use of Dengvaxia
“Because the WHO does not recommend any product at all in general. What they offer is guidance to countries who want to use it. It gives guidelines which become the basis of the countries in terms of its implementation. They will review it again. This vaccine is not just registered in the Philippines but also in 19 countries. All of these countries have a concern because of this one,” Suy said.
UNTV News team tried to get the sides on the issue of two former health secretaries who supervised the mass vaccination of Dengvaxia.
In response, Dr. Paulyn Ubial said she will release a statement regarding the issue during the Senate’s hearing on the controversy on Monday.
Dr. Janette Garin, the Health Secretary during the term of former President Benigno Aquino III, initially said she is ready to face the issue. However, she insisted anew that they implemented the dengue immunization program using Dengvaxia with the guidance and recommendation of the WHO.
Meanwhile, Sanofi Pasteur, the manufacturer of Dengvaxia, has yet to comment on the statement of the international organization. – Aiko Miguel | UNTV News & Rescue
UNTV is a major TV broadcast network with 24-hour programming. An Ultra High Frequency station with strong brand content that appeal to everyone, UNTV is one of the most trusted and successful Philippine networks that guarantees wholesome and quality viewing experience.